Inventiva is a clinical-stage biopharmaceutical company focused on the research and development of oral small molecule therapies for the treatment of patients with MASH and other diseases with ...

Under the liquidity contract granted to Kepler Cheuvreux by Inventiva, the following resources were available in the liquidity account as of 31 December 2024: Cash: € 349,630.55 Number of shares ...

Under the liquidity contract granted to Kepler Cheuvreux by Inventiva, the following resources were available in the liquidity account as of 31 December 2024: At the last half-year report as of 30 ...

Inventiva is a clinical-stage biopharmaceutical company focused on the research and development of oral small molecule therapies for the treatment of patients with MASH and other diseases with ...

The quality of Australia’s internet services has slipped to an embarrassing spot behind global competitors – as a new survey measures the overall digital wellbeing of the country. Dutch ...

On Wednesday, Kepler Cheuvreux began covering Kaufman & Broad S.A. (KOF:FP) (OTC: KFMNF) with a Buy rating and set a price target of €39.10. The firm's analysts pointed to the structural trends ...

On Wednesday, Kepler Cheuvreux initiated coverage on Nexity (EPA:NEXI) SA (NXI:FP), a prominent player in the French real estate market, assigning a Hold rating to the company's shares.

On Wednesday, Kepler Cheuvreux initiated coverage on Nexity (EPA:NEXI) SA (NXI:FP), a prominent player in the French real estate market, assigning a Hold rating to the company's shares. The research ...

MIKE LORIGAN, REPORTER: To the naked eye, the old prospecting town of Bendigo might not seem the most obvious place to unearth elite marathon running gold but as the saying goes: ARCHIVAL ...

Covered windows, peeling wallpaper: For the first time outside of Amsterdam, an exhibition reconstructs Anne’s hiding place during the devastation of the Holocaust. “Anne Frank the Exhibition ...